A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema

Clinical trial NCT01506895 · COMPLETED

Trial details

NCT number: NCT01506895
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Retinopathy, Diabetic

Start date: 2012-02-01
Primary completion: 2013-02-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.